中华全科医学2024,Vol.22Issue(4) :618-621.DOI:10.16766/j.cnki.issn.1674-4152.003464

丁苯酞联合重复经颅磁刺激对脑梗死后轻度认知障碍的疗效观察

Observation on the therapeutic effect of combined butylphthalide and repeated transcranial magnetic stimulation on mild cognitive impairment after cerebral infarction

张淑红 凌迎春 罗方 盛高扬
中华全科医学2024,Vol.22Issue(4) :618-621.DOI:10.16766/j.cnki.issn.1674-4152.003464

丁苯酞联合重复经颅磁刺激对脑梗死后轻度认知障碍的疗效观察

Observation on the therapeutic effect of combined butylphthalide and repeated transcranial magnetic stimulation on mild cognitive impairment after cerebral infarction

张淑红 1凌迎春 2罗方 1盛高扬1
扫码查看

作者信息

  • 1. 龙游县人民医院神经内科,浙江衢州 324400
  • 2. 绍兴市第七人民医院检验科,浙江绍兴 312000
  • 折叠

摘要

目的 探讨丁苯酞联合重复经颅磁刺激治疗脑梗死后轻度认知障碍患者的有效性与安全性,为临床治疗提供借鉴.方法 选取2020年2月-2023年1月龙游县人民医院神经内科收治的190例脑梗死后轻度认知障碍患者,采用随机数表法分为A组(95例)、B组(95例).A组应用丁苯酞治疗,B组应用丁苯酞联合重复经颅磁刺激治疗.比较2组治疗效果、认知功能、脑血流指标、炎症反应指标以及不良反应发生情况.结果 B组治疗总有效率为90.53%(86/95),高于A组的71.58%(68/95,P<0.05).治疗后,2组患者认知功能均有一定程度的改善,且B组患者蒙特利尔认知量表(MoCA)评分明显高于A组[(26.33±2.50)分vs.(24.21±2.84)分,P<0.05].2组患者治疗后血流搏动指数均降低、收缩期血流速度及平均血流速度均升高(P<0.05),且B组治疗后脑血流指标均优于A组(P<0.05).2组治疗后C反应蛋白、肿瘤坏死因子-α、白介素-1β均降低(P<0.05),且B组各指标均低于A组(P<0.05). 2组患者治疗后不良反应发生率比较差异无统计学意义(P>0.05).结论 丁苯酞联合重复经颅磁刺激治疗脑梗死后轻度认知障碍疗效显著,可改善患者的认知功能以及脑血流指标,减轻炎症反应,不良反应少,有效性与安全性兼备,可推行.

Abstract

Objective This study aims to explore the efficacy and safety of combing butylphthalide with repetitive tran-scranial magnetic stimulation for treating mild cognitive impairment in patients following cerebral infarction,offering valu-able insights for clinical treatment.Methods A total of 190 patients with mild cognitive impairment after cerebral infarc-tion were randomly divided into either Group A(n=95)or Group B(n=95)at Longyou People's Hospital from Febru-ary 2020 to January 2023.Group A received butylphthalide treatment,while Group B received a combination of bu-tylphthalide and repetitive transcranial magnetic stimulation.The study aimed to compare the treatment effects,cognitive function,cerebral blood flow indicators,inflammatory reactions indicators,and adverse reactions between the two groups.Results The total effective rate of treatment in Group B(90.53%,86/95)was significantly higher than in Group A(71.58%,68/95,P<0.05).Both groups demonstrated improved cognitive function compared to before treatment,with Group B showing a significantly higher Montreal cognitive assessment(MoCA)score than Group A[(26.33±2.50)points vs.(24.21±2.84)points,P<0.05];After treatment,both groups exhibited decreased pulsatile index of blood flow in both groups of patients decreased,and the systolic and average blood flow velocities of blood flow and increased systolic and average blood flow velocities(P<0.05).However,Group B showed better cerebral blood flow indicators compared to Group A(P<0.05).Post-treatment C-reactive protein,tumor necrosis factor-α,and interleukin-1β de-creased in both groups(P<0.05),with all indicators in Group B being lower than in Group A(P<0.05).There were no significant differences in adverse reactions between the two groups(P>0.05).Conclusion The combination of bu-tylphthalide and repetitive transcranial magnetic stimulation demonstrates a significant therapeutic effect on mild cognitive impairment following cerebral infarction.It effectively improves cognitive function,enhances cerebral blood flow indica-tors,reduces inflammatory reactions,and exhibits minimal adverse reactions.This treatment approach is both effective and safe,warranting its promotion.

关键词

丁苯酞/重复经颅磁刺激/脑梗死/认知障碍/脑血流/炎症反应指标

Key words

Butylphthalide/Repetitive transcranial magnetic stimulation/Cerebral infarction/Cognitive impairment/Cerebral blood flow/Inflammatory response indicators

引用本文复制引用

基金项目

浙江省医药卫生科技计划(2022KY1309)

出版年

2024
中华全科医学
中华预防医学会,安徽省全科医学会

中华全科医学

CSTPCD
影响因子:1.688
ISSN:1674-4152
参考文献量18
段落导航相关论文